DoNews3月31日消息,生物制药领军企业三生制药(01530.HK)发布年度业绩。公告显示,2024年三生制药营业收入约人民币91.08亿元,比去年同期增长16.5%;毛利约人民币78.28亿元,比去年同期增长17.9%;归母净利润20.9亿元,同比增长34.9%;经调整的经营性归母净利润约人民币23.18亿元,比去年同期增长18.8%;董事会宣派2024年股息0.25港元每股。2024年,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.